AKBA logo

AKBAAkebia Therapeutics Inc.

$0.8914
$0.0265
(3.04%)
Today
Closed $0.8994
$0.008
(0.89%)
After Hours
Updated: 07:28 PM EDT
EarningsAug 6
Mkt Cap$234.16M
Vol16.69M

About

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vafseo. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
194

Frequently Asked Questions

What is Market Cap of Akebia Therapeutics Inc.?
What is the 52-week high for Akebia Therapeutics Inc.?
What is the 52-week low for Akebia Therapeutics Inc.?
What is Akebia Therapeutics Inc. stock price today?
What was Akebia Therapeutics Inc. stock price yesterday?
What is the PE ratio of Akebia Therapeutics Inc.?
What is the Price-to-Book ratio of Akebia Therapeutics Inc.?
What is the 50-day moving average of Akebia Therapeutics Inc.?
How many employees does Akebia Therapeutics Inc. have?

Advertisement|Remove ads.